KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Depreciation & Amortization (CF) (2016 - 2026)

Halozyme Therapeutics has reported Depreciation & Amortization (CF) over the past 17 years, most recently at $4.2 million for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 55.56% to $4.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $12.9 million through Mar 2026, up 21.74% year-over-year, with the annual reading at $11.4 million for FY2025, 10.57% up from the prior year.
  • Depreciation & Amortization (CF) was $4.2 million for Q1 2026 at Halozyme Therapeutics, up from $3.3 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $4.2 million in Q1 2026 and troughed at $778000.0 in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $2.7 million (2023), against an average of $2.6 million.
  • Year-over-year, Depreciation & Amortization (CF) skyrocketed 237.02% in 2023 and then decreased 8.47% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.6 million in 2022, then rose by 12.22% to $2.9 million in 2023, then fell by 6.35% to $2.7 million in 2024, then rose by 22.37% to $3.3 million in 2025, then grew by 27.12% to $4.2 million in 2026.
  • Per Business Quant, the three most recent readings for HALO's Depreciation & Amortization (CF) are $4.2 million (Q1 2026), $3.3 million (Q4 2025), and $2.7 million (Q3 2025).